Buffered Crystalloid Solution Doesn't Cut AKI Risk

This article originally appeared here.
Share this content:
Buffered Crystalloid Solution Doesn't Cut AKI Risk
Buffered Crystalloid Solution Doesn't Cut AKI Risk

THURSDAY, Oct. 8, 2015 (HealthDay News) -- Among patients receiving crystalloid fluid therapy in the intensive care unit (ICU), the risk of acute kidney injury is similar for buffered crystalloid versus saline, according to a study published online Oct. 7 in the Journal of the American Medical Association. The research was published to coincide with the annual meeting of the European Society of Intensive Care Medicine, held from Oct. 3 to 7 in Berlin.

Paul Young, M.B., Ch.B., from the Medical Research Institute of New Zealand in Wellington, and colleagues conducted a randomized trial in four ICUs involving 2,278 eligible patients requiring crystalloid fluid therapy. Overall, 1,152 patients receiving buffered crystalloid and 1,110 patients receiving saline were analyzed. Participating ICUs were assigned to either saline or buffered crystalloid for alternating seven-week treatment blocks; two crossovers occurred during the study.

The researchers found that 9.6 and 9.2 percent of patients developed AKI within 90 days after enrollment in the buffered crystalloid and saline groups, respectively (relative risk [RR], 1.04; 95 percent confidence interval [CI], 0.80 to 1.36). Renal replacement therapy was used in 3.3 and 3.4 percent of patients in the buffered crystalloid and saline groups, respectively (RR, 0.96; 95 percent CI, 0.62 to 1.50). Overall, 7.6 and 8.6 percent of patients, respectively, died in the hospital (RR, 0.88; 95 percent CI, 0.67 to 1.17).

"Further large randomized clinical trials are needed to assess efficacy in higher-risk populations and to measure clinical outcomes such as mortality," the authors write.

Several authors disclosed financial ties to the pharmaceutical and medical device industries.

Abstract
Full Text
Editorial
More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

Rising Fatal Drug Overdoses Linked to Years of Life Lost

Rising Fatal Drug Overdoses Linked to Years of ...

Growth in fatal overdoses linked to increased mortality, years of life lost for non-Hispanic whites

Atherosclerotic CVD Mortality Higher in South Asians in the U.S.

Atherosclerotic CVD Mortality Higher in South Asians in ...

Most of the increased risk can be attributed to increased prevalence of known risk factors

Global Variation in Personal Health Care Access and Quality

Global Variation in Personal Health Care Access and ...

Highest performance in Iceland, lowest in Central African Republic, with variation in rate of progress